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It has been reported that the transport function for organic anions on the kidney is maintained in multidrug resistance-associated protein 2 (Mrp2)-
deficient rats. Different from Mrp2-deficient rats, Long–Evans Cinnamon (LEC) rats have impaired urinary excretion of Mrp2-substrate,
phenolsulfonphthalein (PSP). PSP is transported by the potential-sensitive urate transport system in rat brush-border membranes. We analyzed the
function of PSP transport system in LEC rats. Unlike Long–Evans Agouti (LEA) rats, the initial uptake of PSP and urate into the renal brush-border
membrane vesicles of LEC rats were not significantly enhanced in the presence of positive intravesicular potential, suggesting that the potential-
sensitive urate transport system is impaired in LEC rats. LEC rats should be useful for elucidating the potential-sensitive urate transport system in rats
at the molecular level.
© 2007 Elsevier B.V. All rights reserved.Keywords: LEC rats; Urinary excretion; Transporter; Organic anion; Urate1. Introduction
A mutant strain of inbred Long–Evans rats that spontane-
ously develop acute hepatitis associated with jaundice, chronic
hepatitis, and ultimately hepatocellular carcinoma, the Long–
Evans Cinnamon (LEC) strain, has been established [1]. LEC
rats suffer from fulminant hepatitis and severe jaundice at about
4 months of age [2]. Furthermore, liver cancer appears in long-
surviving rats after recovery from jaundice [3,4]. Therefore,
LEC rats provide a pertinent model for basic and clinical studies
on hepatitis and liver cancer.
Multidrug resistance-associated protein 2 (Mrp2/Abcc2)
has been shown to mediate the transport of endobiotics (e.g.,
bilirubin and bilirubin conjugates). Mutations in the Mrp2
gene have been identified as the pathogenetic basis of
hereditary chronic conjugated hyperbilirubinemia [5]. The⁎ Corresponding author. Kita 12-jo, Nishi 6-chome, Kita-ku, Sapporo 060-
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doi:10.1016/j.bbamem.2007.09.025function of Mrp2 has been extensively studied by comparing
the transport across the bile canalicular membrane in normal
rats and that in Mrp2-deficient rats (e.g., Eisai hyperbilir-
ubinemic rats (EHBR), transport deficient (TR−) and Gronin-
gen Yellow (GY)) [6–8]. These animals have a defect in the
hepatobiliary excretion of a broad range of organic anions,
including bilirubin glucuronides and other multivalent organic
anions. However, it has been reported that the transport
function for organic anions on the kidney is maintained in
these animals and that the contribution of Mrp2 to urinary
excretion is minor [9,10].
Sulfobromophthalein (BSP) and phenolsulfonphthalein
(PSP) are widely used clinically as drugs for testing liver
function and renal function, respectively [11,12]. A previous
study has revealed that LEC rats have not only impaired
canalicular transport of BSP but also impaired urinary
excretion of PSP [13]. However, urinary nitrogen and
creatinine did not show serious renal failure [14]. These
results suggest that the function of the renal secretion system
for PSP in LEC rats is impaired.
Fig. 1. Concentration dependence of the uptake of PSP by kidney slices. The uptake
by kidney slices was measured at PSP concentrations of 25 μM to 1 mM over a
period of 30 min. Each value represents the mean with SD of four determinations.
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properties of the renal transport system for PSP inLEC rats. In this
study, we used Long–Evans Agouti (LEA) rats as a control.
2. Materials and methods
2.1. Chemicals
PSP was purchased from Wako Pure Chemical (Osaka, Japan). Probenecid
was purchased from Sigma Chemical Co. (St. Louis, MO). [3H]p-Aminohippu-
rate (PAH) (4.90 Ci/mmol) was purchased from NEN Life Science Products
(Hoofddrop, The Netherlands). [14C] Urate (54 mCi/mmol) was purchased from
Moravek Biochemicals, Inc. (Brea, CA). All other reagents were of the highest
grade available and used without further purification.
2.2. Animals
Male LEC and LEA rats, aged 6 to 9 weeks (200–250 g in weight), were
obtained from the Center for Experimental Plants and Animals of HokkaidoFig. 2. Effect of a positive intravesicular potential on PSP uptake by LEA and LEC
100 mM Na-gluconate and 20 mM HEPES/Tris (pH 7.4), and treated either with va
100 mM D-mannitol, 120 μM PSP, 100 mM K-gluconate and 20 mM HEPES/Tris
represents the mean with SD of three determinations ⁎Pb0.05, significantly differenUniversity (Sapporo, Japan). The housing conditions were described previously
[15]. The experimental protocols were reviewed and approved by the Hokkaido
University Animal Care Committee in accordance with the “Guide for the Care
and Use of Laboratory Animals” as adopted by the National Institutes of Health.
2.3. Study of uptake by kidney slices
Uptake studies were carried out as described in our previous report [16]. Slices
of whole kidneys from rats were put in ice-cold oxygenated incubation buffer. The
incubation buffer consisted of 120mMNaCl, 16.2mMKCl, 1mMCaCl2, 1.2mM
MgSO4, and 10mMNaH2PO4/Na2HPO4 adjusted to pH 7.5. Slices (80 to 100mg)
were incubated in a 6-well plate with 3 ml of oxygenated incubation buffer in each
well after they had been preincubated with incubation buffer for 5 min. The uptake
of PSP by kidney slices was measured at PSP concentrations of 25 μM to 1 mM
over a period of 30 min at 37 °C. After incubation, each slice was immediately
removed from the incubation buffer, washed with ice-cold saline, weighed, and
homogenized in 0.5 ml saline and the same volume of methanol. After
centrifugation (15,000×g for 15 min) of the mixture, the concentration of PSP in
the supernatant was measured.
2.4. Preparation of brush-border membrane vesicles
Renal brush-border membrane vesicles (BBMV) were prepared from the rat
kidney by the calcium precipitation method with some modification as described
previously [17]. The purified membranes were suspended in a buffer containing
100 mM D-mannitol, 100 mMKCl and 20 mMHEPES/Tris (pH 7.4) or 100 mM
D-mannitol, 100 mM Na–gluconate and 20 mM HEPES/Tris (pH 7.4). Alkaline
phosphatase (a marker enzyme of the brush-border membrane) activity levels of
the LEA and LEC rat brush-border membrane were 11.2±1.3-fold and 12.1±
1.7-fold higher than those of the initial homogenates (mean with S.D. of 6
preparations), respectively. In contrast, Na+–K+ ATPase (a marker enzyme of the
basolateral membrane) activity level of the LEA and LEC rat brush-border
membrane were 1.3±0.2-fold and 1.1±0.2-fold higher than those of the initial
homogenates (mean with S.D. of 6 preparations, Pb0.01, significantly different
from the ratio of alkaline phosphatase), respectively. These findings indicate that
brush-border membranes were enriched at least 10-fold with respect to the
basolateral membranes.
2.5. Study of uptake by brush-border membrane vesicles
The uptake of substrates into BBMV was determined by the rapid filtration
technique described previously [18]. In a routine assay, 40 μl of membrane
vesicles (0.4–0.6 mg protein) suspension was added to 200 μl of substraterat renal BBMV. Membrane vesicles were suspended in 100 mM D-mannitol,
linomycin (7 μg/mg protein) or ethanol (control). The drug solution contained
(pH 7.4). Uptake of PSP was determined after 1 min of incubation. Each point
t from the control.
Table 1
Effects of various compounds on the potential-stimulated substrate uptake
Potential-stimulated uptake (% of Control)
PSP Urate
Control 100 100
Probenecid 37.0±4.09⁎ 27.5±15.2⁎
Urate 23.6±1.87⁎ –
PSP – 38.5±4.03⁎
Incubation conditions were identical to those described in the legends to Figs. 2
and 3. Potential-stimulated uptake was obtained as the difference between the
uptake in the presence of positive intravesicular potential and that in the absence
of positive intravesicular potential. Each point represents the mean with S.D. of
3–6 preparations. The control values for potential-stimulated uptake of PSP and
urate were 90.3±9.72 and 9.75±0.68 pmol/mg protein, respectively. ⁎Pb0.05,
significantly different from the control.
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figure legends. After incubation for 1 min, the uptake was stopped by diluting
the incubation medium with 5 ml of ice-cold 10 mM HEPES buffer (pH 7.4)
containing 150 mM KCl. The mixture was immediately filtered through a
Millipore filter (0.45 μm in pore size, 2.5 cm in diameter; HAWP). The filter
was rinsed with 3 ml of the same buffer. Substrate trapped on the filter was
extracted with 300 μl of water, and the concentration of substrate was
determined. In experiments where valinomycin was used, the ionophore
dissolved in ethanol (150 μg/ml), or ethanol alone as a control, was added
30 min prior to the assay. The final concentration of ethanol was 0.1%. To
assay the radiolabeled compounds, substrate trapped on the filter was ex-
tracted with 10 ml of ACSII (Amersham International, UK), and the radio-
activity was determined.
2.6. Analytical procedures
PSP was determined using an HPLC system equipped with a Hitachi L-6000
pump and L-4200H UV/VIS detector described previously [19]. The column
was a Hitachi ODS Gel #3053 (4 mm i.d.×250 mm). Column temperature and
flow rate were 55 °C and 0.7 ml/min, respectively. In the assay for PSP, a mobile
phase containing 20% acetonitrile and 50 mMH3PO4 with pH adjusted to 3.0 by
NaOH was used. The wavelength of the detector for PSP was 432 nm.
Radioactivity was determined using a liquid scintillation counter (Packard,
1600TR). Protein was measured by the method of Lowry et al. with bovine
serum albumin as a standard [20]. Student's t-test was used for statistical
analysis, and a value of Pb0.05 was considered significant.Fig. 3. Effect of a positive intravesicular potential on urate uptake by LEA and LEC
100 mM Na-gluconate and 20 mM HEPES/Tris (pH 7.4), and treated either with va
100 mM D-mannitol, 48 μM [14C]urate, 100 mM K-gluconate and 20 mM HEPES/Tr
represents the mean with SD of three determinations ⁎Pb0.05, significantly differe3. Results
3.1. Characteristics of the renal uptake system for PSP in LEC
rats
Secretion of organic anions in renal proximal tubules involves
the uptake of organic anions across basolateral membranes into
cells and exit into the lumen across brush-bordermembranes [21].
We recently reported that rat organic anion transporters 1 and 3
(rOat1/Slc22a6 and rOat3/Slc22a8) are involved in the renal
uptake of PSP and that PSP is a high-affinity substrate for rOat3
but is a relatively low-affinity substrate for rOat1 [16]. The first
experiment was performed to evaluate the renal uptake of PSP in
LEC rats. The uptake of PSP by slices of kidneys from LEA and
LEC rats was examined. The uptake of PSP by kidney slices at
30 min was used to examine the concentration-dependence. The
uptake behavior of PSP was almost the same in each rat (Fig. 1).
3.2. Potential-sensitive transport system in LEC rats
Next we evaluated the exit system of PSP in LEC rats. The
uptake of PSP into the renal BBMVof LEA and LEC rats was
examined. We recently reported that PSP has high affinity for the
potential-sensitive urate transport system [22]. When an inside-
positive membrane potential was created by applying an inwardly
directed K+ gradient in the presence of the K+ ionophore
valinomycin, the uptake of PSP into the renal BBMVof LEA rats
was significantly accelerated compared that in the absence of
valinomycin (Fig. 2), and PSP uptake stimulated by the inside-
positive membrane potential was significantly inhibited by
probenecid, an organic anion transporter inhibitor (Table 1). On
the other hand, the uptake of PSP into the renal BBMVof LEC
rats was not significantly enhanced by positive intravesicular
potential (Fig. 2). Next, the effect of positive intravesicular
potential on the uptake of urate into the renal BBMVof LEA and
LEC rats was investigated. As well as the uptake of PSP, the
uptake of urate into the renal BBMVof LEA rats was significantly
accelerated by positive intravesicular potential, but that of LECrat renal BBMV. Membrane vesicles were suspended in 100 mM D-mannitol,
linomycin (7 μg/mg protein) or ethanol (control). The drug solution contained
is (pH 7.4). Uptake of urate was determined after 1 min of incubation. Each point
nt from the control.
Fig. 4. Effect of a positive intravesicular potential on PAH uptake by LEC rat renal BBMV. Membrane vesicles were suspended in 100 mM D-mannitol, 100 mM Na-
gluconate and 20 mMHEPES/Tris (pH 7.4), and treated either with valinomycin (7 μg/mg protein) or ethanol (control). The drug solution contained 100 mM D-mannitol,
2.4 μM [3H] PAH, 100 mMK-gluconate and 20 mMHEPES/Tris (pH 7.4). Uptake of PAH was determined after 1 min of incubation. Each point represents the mean with
SD of three determinations. ⁎Pb0.05, significantly different from the control.
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intravesicular potential (Fig. 3). Moreover, urate and PSP uptake
into the renal BBMVof LEA rats stimulated by the inside-positive
membrane potential was significantly inhibited by PSP and urate,
respectively (Table 1). On the other hand, probenecid, urate and
PSP had no effect on the initial uptakes of substrates into the renal
BBMVof LEC rats (data not shown).
In rats, in addition to the potential-sensitive urate transport
system, the potential-sensitive PAH transport system has been
thought to be present in the brush-border membrane [23,24]. We
have shown that PSP has low affinity for the potential-sensitive
PAH transport system [22]. The function of the potential-sensitive
PAH transport system in LEC rats was evaluated. The uptake of
PAH into the renal BBMVof LEA and LEC rats was examined. In
the presence of positive intravesicular potential, PAH uptake was
significantly accelerated compared with that in the absence of
positive intravesicular potential (Fig. 4). Moreover, D-glucose
uptake into the renal BBMV of LEA and LEC rats was
stimulated by the inside-positive membrane potential (3.2±0.5-
fold and 2.9±0.4-fold higher than those in the absence of positive
intravesicular potential, respectively).
4. Discussion
The LEC rat is a mutant strain established at the Center for
Experimental Plants and Animals of Hokkaido University [1].
LEC rats, like Mrp2-deficient rats, exhibit hyperbilirubinemia
[2]. However, different from Mrp2-deficient animals, LEC rats
have not only impaired canalicular transport of BSP but also
impaired urinary excretion of PSP [13]. Thus, we focused on the
urinary excretion of PSP in LEC rats. We previously reported
that PSP was transported by some transport systems, rOat3,
rOat1 and a potential-sensitive urate transport system and that
the contribution of organic anion exchanger to the excretion of
PSP is minor [16,22]. Thus, it is possible that dysfunction of one
or some of these transport systems for PSP is responsible for the
reduction of PSP excretion in LEC rats. The purpose of this
study was to clarify the cause of the impairment of the renal
transport system for PSP in LEC rats.In the first part of this study, we investigated the function
of basolateral organic anion transporters in LEC rats. No
significant difference was found between the uptake of PSP by
slices of kidneys from LEA rats and that by slices of kidneys
from LEC rats. These results suggest that the functions of
organic anion transporters in the renal basolateral membrane are
normal in LEC rats.
In the next part of this study, we investigated the function of
brush-border organic anion transporters in LEC rats. We
recently reported that the efflux of PSP from proximal cells to
the tubular lumen occurs through a potential-sensitive urate
transport system [22]. In the presence of an inwardly directed
K+ gradient, the initial uptakes of PSP and urate into the renal
BBMV of LEC rats were not significantly enhanced compared
with that in the absence of valinomycin. Moreover, the uptake
of urate into the renal BBMV of LEA rats stimulated by the
inside-positive membrane potential was significantly inhibited
by PSP. Taking these findings into consideration, we conclude
that potential-sensitive urate transport system in LEC rats is
impaired. In rat renal brush-border membranes, it is thought that
the potential-sensitive PSP/urate transport system is different
from the potential-sensitive PAH transport system [23,24].
Finally, we investigated the function of this transport system in
LEC rats. In the presence of a positive intravesicular potential,
the uptake of PAH into the renal BBMV of LEC rats was
significantly enhanced. This find indicates that the potential-
sensitive PAH transport system in LEC rats is normal. Although
the aim of this study is to investigate the efflux pathway, we
performed uptake studies using brush-border membrane
vesicles [23,24]. Since transporters are not symmetric, different
results can be obtained depending on the direction of the fluxes
that are measured. Further studies are needed to elucidate the
function of this transporter more precisely.
The renal excretion of urate is the result of rather complex
mechanisms [25]. Due to the complexity of the mechanism of
renal transport of urate, it is difficult to predict in vivo urate
disposition from in vitro data [26]. The major models of renal
urate handling include filtration, reabsorption, secretion, and
postsecretory reabsorption. Recently, the long-hypothesized urate
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urate–anion exchanger regulating blood urate levels, was
identified [27]. It has been reported that the potential-sensitive
transport system plays an important role in the efflux of organic
anions across brush-border membranes in rats, because the
intracellular compartment has a more negative electrical potential
than that of the luminal fluid compartment in proximal tubules
[28]. However, the transporter that is responsible for the secretion
of urate in rats has not yet been elucidated at the molecular level.
LEC rats should be useful for elucidating the potential-sensitive
urate transport system in rats at the molecular level.
To date, a novel potential-sensitive transporter (OATv1) has
been identified at the brush-border membranes of pig renal
proximal tubules [29]. In addition to OATv1, a mouse renal-
specific transporter (RST) is a classical facilitative transporter at
the brush-border membranes of renal proximal tubules, which has
been hypothesized to be involved in the efflux of organic anions
including urate [30].We have suggested that the rat homologue of
mouse RST plays amajor role in the renal secretion of PSP [22]. It
is possible that this transport system in LEC rats is impaired.
Moreover, urate transporter/channel (UAT) have been proposed
to be involved in renal urate transport [31]. Further studies are
needed to elucidate the function of these transport systems in LEC
rats.
In summary, the functions of basolateral organic anion trans-
porters in the renal proximal tubules of LEC rats are normal;
however, a functional disorder of the potential-sensitive urate
transport system is responsible for the marked reduction in urinary
excretion of PSP in LEC rats.
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